- £1.09m
- -£0.37m
- £0.03m
Fundraising of up to £1,050,000
Inaphaea Commercial update
Half-year Report
Inaphaea Commercial Update
Cytolytix Commercial update
Brief: ValiRx Establishes A New Wholly Owned Subsidiary Blue Ribbon Bio Limited
Commercial update
Update on Evaluation Agreement with Stingray Bio
Brief: ValiRx Announces Licensing Agreement With Dominion Biotech
Licensing Agreement with Dominion Biotech Ltd
Brief: ValiRx Announces Collaboration Agreement With Voxcell Bioinnovation
Collaboration Agreement with Voxcell BioInnovation
Holding(s) in Company
Final Results & Notice of AGM
Brief: ValiRx Announces Evaluation And Material Transfer Agreement With Omios Biologics
New Evaluation and Material Transfer Agreement
Holding(s) in Company
Commercial Update
Brief: Valirx Terminates LOI With TheoremRx